1、本次征集投票权的征集人为公司现任独立董事汪律先生，其基本情况如 下： 汪律，男，汉族，1989 年 3 月生，2011 年 7 月毕业于安徽大学法学院，本 科学历，法律硕士学位。 先后任职于中国人寿财产保险股份有限公司安徽省分公司法务，安徽省信用 融资担保集团有限公司公司律师、法务、项目经理；2018 年任安徽省科技融资 担保有限公司监事、风险管理与法律事务部副总经理、公司律师；现为安徽承义 证券代码：600186 证券简称：莲花健康 公告编号：2023—053 莲花健康产业集团股份有限公司 独立董事公开征集委托投票权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 根据中国证券监督管理委员会（以下简称"中国证监会"）颁布的《上市公 司股权激励管理办法》（以下简称"《管理办法》"）的有关规定，莲花健康产 业集团股份有限公司（以下简称"公司"）独立董事汪律先生作为征集人，就公 司拟于 2023 年 8 月 30 日召开的 2023 年第二次临时股东大会审议的有关议案向 公司全体股东征集投票权。 一、征集 ...

莲花健康产业集团股份有限公司 2023 年股票期权与限制性股票激励计划首次授予激励对象 名单 一、激励对象获授的股票期权分配情况 | 序号 | 姓名 | | 职务 | 获授的股 | 占本激励计划 | 占本计划公告日 | | --- | --- | --- | --- | --- | --- | --- | | | | | | 票期权数 | 授予股票期权 | 股本总额的比例 | | | | | | 量 (万份) | 总数的比例 | | | 1 | 李 | 斌 | 副董事长 | 50.0000 | 5.1596% | 0.0279% | | 2 | 曹家胜 | | 总裁 | 35.0000 | 3.6117% | 0.0195% | | 3 | 李 | 涛 | 联席总裁 | 30.0000 | 3.0958% | 0.0167% | | 4 | 郑德洲 | | 董事 | 25.0000 | 2.5798% | 0.0139% | | 5 | | | 董事兼党委 | | | | | | 郭 | 剑 | 书记、工会 | | | | | | | | 主席 | 25.0000 | 2.5798% | 0.0139% | ...

关于第九届监事会第二次会议相关事项的核查 意见 莲花健康产业集团股份有限公司监事会 根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证 券法》（以下简称《证券法》）、《上市公司股权激励管理办法》（以下简称"《管理 办法》"）等相关法律法规、规范性文件及《公司章程》的有关规定，作为莲花健 康产业集团股份有限公司（以下简称"公司"）第九届监事会成员，我们对公司 《2023 年股票期权与限制性股票激励计划（草案）》及其摘要、《2023 年股票期 权与限制性股票激励计划考核管理办法》及公司 2023 年股票期权与限制性股票 激励计划激励对象名单进行了仔细阅读和审核，发表核查意见如下： 一、监事会对《2023 年股票期权与限制性股票激励计划（草案）》及其摘要 的核查意见 经审核，监事会认为： 1、公司不存在《管理办法》等相关法律、法规规定的禁止实施股权激励计 划的情形，公司具备实施股权激励计划的主体资格； 2、 本次激励计划（草案）的拟定、审议流程、内容符合《管理办法》等相 关法律、法规及规范性文件的规定，未侵犯公司及全体股东的利益； 3、 公司本次激励计划不存在为激励对象依本计划获取有关权益提供贷 ...

| | 证券代码：600186 | 证券简称：莲花健康 | 公告编号：2023— | | --- | --- | --- | --- | | 0 | | 5 | 1 | 莲花健康产业集团股份有限公司 2023年股票期权与限制性股票激励计划（草案）摘 要 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本激励计划拟向激励对象授予权益总计1,938.1400万份，涉及的标的股 票种类为人民币 A股普通股，约占本激励计划公告日公司股本总额 179,390.1141万股的1.0804%。其中，首次授予权益1,600.0000万股，约占本 激励计划公告日公司股本总额179,390.1141万股的0.8919%，占本激励计划 授出权益总量的82.5534%；预留权益338.1400万股，约占本激励计划公告日 公司股本总额179,390.1141万股的0.1885%，占本激励计划授出权益总量的 17.4466%。 一、公司基本情况 （一）公司简介 公司名称：莲花健康产业集团股份有限公司 法定代表人：李厚文 注册资本：179, ...

莲花健康产业集团股份有限公司独立董事 关于第九届董事会第二次会议相关事项的独立意见 根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和 国证券法》（以下简称《证券法》）、《上市公司治理准则》、《关于在上市公 司建立独立董事制度的指导意见》及《上海证券交易所股票上市规则》等相关法 律、法规和规范性文件及《莲花健康产业集团股份有限公司章程》（以下简称"《公 司章程》"）《莲花健康产业集团股份有限公司独立董事制度》的有关规定，作 为莲花健康产业集团股份有限公司（以下简称"公司"）的独立董事，本着认真、 负责的态度，基于独立、审慎、客观的立场，我们对公司第九届董事会第二次会 议审议的相关事项进行了认真审核，并发表独立意见如下： （2）最近 12 个月内被中国证监会及其派出机构认定为不适当人选； （3）最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政 处罚或者采取市场禁入措施； （4）具有《公司法》规定的不得担任公司董事、高级管理人员情形的； （5）法律法规规定不得参与上市公司股权激励的； （6）中国证监会认定的其他情形。 （一）关于公司《2023 年股票期权与限制性股票激励计划（草案） ...

证券代码：600186 证券简称：莲花健康 公告编号：2023-038 莲花健康产业集团股份有限公司 关于召开 2022 年度业绩说明会的公告 投资者可于 2023 年 05 月 09 日(星期二) 至 05 月 15 日(星期 一)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 lhg@mylotushealth.com 进行提问。公司将在说明会上 对投资者普遍关注的问题进行回答。 莲花健康产业集团股份有限公司（以下简称"公司"）已于 2023 年 3 月 31 日发布公司《公司 2022 年年度报告》及其摘要，为便于广 大投资者更全面深入地了解公司 2022 年度经营成果、财务状况，公 司计划于 2023 年 05 月 16 日 下午 15:00-16:00 举行 2022 年度业绩 说明会，就投资者关心的问题进行交流。 一、 说明会类型 会议召开时间：2023 年 05 月 16 日(星期二) 下午 15:00-16:00 会 议 召 开 地 点 ： 上海证券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会 ...

Financial Performance - The company's operating revenue for the first half of 2018 was ¥849,033,063.84, a decrease of 4.28% compared to ¥886,958,016.48 in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2018 was -¥59,038,464.40, slightly improved from -¥60,299,296.46 in the previous year[18]. - The net cash flow from operating activities was -¥18,748,259.28, compared to -¥19,675,057.15 in the same period last year[18]. - The total assets at the end of the reporting period were ¥1,904,585,696.52, reflecting a 0.81% increase from ¥1,889,231,700.08 at the end of the previous year[18]. - The net assets attributable to shareholders decreased to -¥24,896,115.15, a decline of 172.92% from ¥34,142,349.25 at the end of the previous year[18]. - The basic earnings per share for the first half of 2018 was -¥0.0556, slightly improved from -¥0.0568 in the same period last year[19]. - The weighted average return on net assets was -1,277.03%, a significant decrease of 1,220.9 basis points compared to -56.13% in the previous year[19]. - The company's operating revenue for the reporting period was ¥849,033,063.84, a decrease of 4.28% compared to ¥886,958,016.48 in the same period last year[30]. - The operating cost decreased by 6.67% to ¥744,725,867.68 from ¥797,938,547.58, attributed to reduced sales volume and revenue[30]. - The net cash flow from operating activities improved by 4.71%, reaching -¥18,748,259.28 compared to -¥19,675,057.15 in the previous year[30]. Cash Flow and Investments - The net cash flow from investing activities significantly increased by 283.47%, amounting to ¥10,353,803.18, up from -¥5,643,177.35[30]. - The net cash flow from financing activities rose by 36.06% to ¥22,123,288.52 from ¥16,259,414.86, indicating increased bank borrowings[30]. - The company reported a significant increase in cash and cash equivalents, which rose by 85.49% to ¥29,882,091.07 from ¥16,109,820.58[32]. - The accounts receivable increased by 461.02%, reaching ¥14,696,403.61 compared to ¥2,619,583.25 in the previous period[32]. Business Operations and Strategy - The company has established a complete integrated circular economy industrial chain based on the production of monosodium glutamate, chicken essence, and flour[24]. - The company is recognized as a key enterprise by the State Council and has received multiple quality awards, enhancing its brand advantage[26]. - The company is focusing on upgrading its product and industry structure to improve brand management and market control capabilities[28]. - The company is exploring potential mergers and acquisitions to strengthen its market position and drive growth[96]. Risks and Challenges - The company faces management risks due to the expansion of its business scale, which may weaken its market competitiveness if management cannot adapt[38]. - Market environment risks are present as the company's performance is closely tied to macroeconomic conditions and product pricing influenced by supply and demand dynamics[38]. - Environmental policy risks could increase operational costs if national standards for pollution control become stricter, impacting profitability[38]. - Raw material price volatility poses a risk, particularly with rising costs for key inputs like corn, which may not align with product pricing[39]. - Aging production facilities and high production costs are challenges, as outdated equipment leads to inefficiencies and safety risks[40]. Legal Matters - The company has ongoing significant litigation, including a case involving a loan dispute with a rural credit cooperative, which is currently under appeal[45]. - The company is involved in multiple lawsuits with total amounts claimed reaching approximately ¥215.37 million, including a significant case involving a loan guarantee of ¥215,367,076.00[48]. - The company has ongoing litigation related to sales contracts, with amounts claimed including ¥2,651,650.04 and ¥1,302,066.08, indicating active disputes in its operational agreements[47]. - The company is currently negotiating settlements in several cases, including a loan dispute of ¥40,737,564.52, which is under discussion for resolution[48]. Environmental Compliance - The company has committed to environmental protection investments, although future regulatory changes may require additional expenditures[38]. - The company maintained a stable operation of its environmental protection facilities, including the installation of an online monitoring system for wastewater, which is connected to environmental authorities for real-time monitoring[60]. - The company achieved compliance with all external pollutant discharge standards, with COD emissions controlled below 100 mg/L, significantly lower than the national standard of 200 mg/L[59]. - The company has implemented a comprehensive environmental monitoring plan, conducting regular tests on wastewater and preparing for emergency environmental monitoring in case of pollution incidents[63]. Shareholder Information - The company reported a total of 87,743 common stock shareholders by the end of the reporting period[67]. - The top ten shareholders hold a total of 125,122,472 shares, representing 11.7% of the company[68]. - The largest shareholder, Zhejiang Ruikang Investment Co., Ltd., holds 11.7% of the shares without any restrictions[68]. - The company has a significant shareholder structure, with Zhejiang Ruikang Investment Co., Ltd. holding 10.36% of the total shares[105]. Accounting and Financial Reporting - The financial statements are prepared based on the going concern assumption, indicating no significant issues affecting the company's ability to continue operations for at least 12 months[111]. - The financial statements comply with the relevant accounting standards and accurately reflect the company's financial position as of June 30, 2018[112]. - The company's accounting period follows the calendar year, from January 1 to December 31[113]. - The company has not disclosed any significant changes in accounting policies or estimates during the reporting period[64]. Equity and Liabilities - Total liabilities rose to CNY 2,088,753,477.98, compared to CNY 2,000,012,340.09, indicating an increase of about 4.4%[76]. - Total equity showed a negative balance of CNY -184,167,781.46, worsening from CNY -110,780,640.01[76]. - The total amount of minority interests decreased by CNY 73,387,000, representing a decline of approximately 14.34%[95]. - The company’s capital reserve increased by CNY 82,922,000, reflecting a growth of about 5.00%[96].

Financial Performance - In 2017, the company's operating revenue was CNY 1,852,912,238.60, an increase of 4.88% compared to CNY 1,766,772,730.42 in 2016[20] - The net profit attributable to shareholders was a loss of CNY 103,432,698.68, a decrease of 258.52% from a profit of CNY 65,247,448.11 in 2016[20] - The total assets at the end of 2017 were CNY 1,889,231,700.08, down 8.98% from CNY 2,075,509,884.20 in 2016[20] - The net assets attributable to shareholders decreased by 75.18% to CNY 34,142,349.25 from CNY 137,575,047.93 in 2016[20] - The basic earnings per share for 2017 was -CNY 0.10, a decrease of 266.66% from CNY 0.06 in 2016[21] - The weighted average return on equity was -120.47%, a decrease of 177.47 percentage points from 57.00% in 2016[21] - The cash flow from operating activities showed a net outflow of CNY 31,281,205.63, compared to an outflow of CNY 30,209,699.42 in 2016[20] - The company reported a net profit of -103,523,760.30 RMB for 2017, compared to a profit of 65,247,448.11 RMB in 2016, indicating a significant decline in profitability[59] - The company reported a total profit for the year of CNY -109,461,310.25, down from CNY 161,973,906.90 in the previous year, reflecting a decrease of over 167%[150] Revenue and Sales - The company achieved a total sales revenue of ¥1.85 billion in 2017, representing a year-on-year growth of 4.88%[32] - The company achieved total sales revenue of RMB 1.852 billion in 2017, an increase of 4.88% compared to the previous year[34] - The sales volume of monosodium glutamate reached 172,380.78 tons, with a production volume of 150,278.94 tons, showing a slight increase in sales volume of 0.08%[39] - The gross profit margin for monosodium glutamate decreased by 1.58 percentage points to 11.66%[38] Investments and Expenditures - The company invested RMB 12 million in upgrading air odor treatment equipment, aiming for improved operational safety[33] - The net cash flow from investment activities significantly improved to RMB 123.63 million, compared to a negative RMB 12.88 million in the previous year[45] - The company plans to accelerate the development of new health-oriented products, including healthy grains, sports drinks, and healthy cooking oils[54] - The company is considering strategic acquisitions to bolster its product portfolio, with a budget of 100 million allocated for potential deals[101] Market and Strategic Initiatives - The company is transitioning towards smart agriculture and health sectors as part of its strategic planning, aiming to integrate resources and enhance operational efficiency[32] - The company has established a national marketing network, ensuring high customer loyalty and a robust service system[30] - The company aims to enhance brand value and expand profit margins by increasing product categories and market presence[54] - The domestic monosodium glutamate industry has undergone significant consolidation, with fewer than 20 manufacturers remaining, leading to a concentrated market structure[52] - The global average annual compound growth rate for the monosodium glutamate market is expected to maintain around 5%[48] Legal and Compliance Issues - The company has been involved in a legal dispute regarding a loan contract, with an appeal filed after an initial judgment[66] - The company has ongoing litigation with various parties, with amounts involved ranging from ¥73,983.40 to ¥40,737,564.52, indicating a diverse range of legal challenges[69] - The company has been ordered to repay amounts related to multiple loan agreements, with ongoing execution processes for these judgments[68] - The company has not disclosed any major litigation or arbitration matters for the current year, indicating a stable legal standing[66] Corporate Governance and Management - The company has emphasized the importance of adapting to market dynamics and technological innovations to maintain competitive advantages[56] - The company has established a performance evaluation system based on market conditions and strategic changes to enhance employee motivation and economic efficiency[109] - The board of directors consists of members who fulfill their duties in accordance with legal and regulatory requirements, ensuring independent operation[114] - The company has established a fair and transparent performance evaluation and incentive mechanism for senior management[115] Financial Position and Assets - Total current assets decreased from CNY 644,450,409.01 at the beginning of the year to CNY 578,695,608.80 at the end of the year, a decline of approximately 10.19%[139] - Cash and cash equivalents dropped significantly from CNY 31,576,167.66 to CNY 16,109,820.58, representing a decrease of about 48.94%[139] - The company's total assets decreased from CNY 2,075,509,884.20 to CNY 1,889,231,700.08, a reduction of approximately 9.00%[141] - The equity attributable to the parent company decreased from CNY 137,575,047.93 to CNY 34,142,349.25, a decline of about 75.16%[141] Future Outlook - The company provided an optimistic outlook for Q4 2023, projecting revenue growth of 25% compared to the previous quarter[101] - New product launches are expected to contribute an additional 200 million in revenue over the next fiscal year[102] - The management emphasized a focus on sustainability initiatives, aiming to reduce carbon emissions by 30% by 2025[102] - Overall, the company remains committed to long-term growth strategies, with a focus on innovation and market leadership[102]

Financial Performance - Net profit attributable to shareholders of the listed company was CNY -29,543,921.35, a decrease of 33.6% year-on-year[6]. - Operating revenue for the period was CNY 429,018,630.08, down 0.62% from the previous year[6]. - The company reported a significant decrease in operating income due to changes in financial performance metrics[11]. - Total operating revenue for Q1 2018 was ¥429,018,630.08, a decrease of 0.39% from ¥431,692,360.84 in the previous period[23]. - The net loss for Q1 2018 was ¥35,108,610.25, an improvement compared to a net loss of ¥47,858,876.80 in the same period last year, reflecting a decrease in losses of 26.7%[24]. - The company's gross profit margin for Q1 2018 was approximately -7.95%, compared to -9.93% in the previous year[23]. - Operating profit for Q1 2018 was -¥34,722,898.48, compared to -¥51,457,682.35 in the previous year, indicating a reduction in operating losses of 32.5%[23]. Cash Flow - The net cash flow from operating activities was CNY -29,761,956.47, compared to CNY -3,262,619.41 in the same period last year[6]. - Cash inflow from sales of goods and services decreased to ¥445,301,451.04 from ¥506,396,844.74, a decline of approximately 12%[29]. - Cash inflow from operating activities totaled ¥447,020,405.53, down from ¥521,122,288.46, a decrease of approximately 14%[29]. - Cash paid for purchasing goods and services was ¥398,305,029.31, a decrease from ¥435,986,721.88, indicating a reduction of about 9%[29]. - Cash paid to employees was ¥45,340,587.50, down from ¥48,139,575.32, a decline of approximately 6%[29]. - Cash inflow from investment activities was negative at -¥2,026,069.33, compared to -¥1,833,300.04 in the previous period, reflecting an increase in cash outflow[30]. - Cash inflow from financing activities was ¥26,000,000.00, with a net cash flow of ¥24,168,651.78, a significant improvement from -¥1,844,935.00 in the previous period[30]. Assets and Liabilities - Total assets decreased by 1.25% to CNY 1,865,585,136.03 compared to the end of the previous year[6]. - Total assets decreased from CNY 1,889,231,700.08 to CNY 1,865,585,136.03, reflecting a decline in both current and non-current assets[15]. - Total liabilities increased from CNY 2,000,012,340.09 to CNY 2,011,474,386.29, with current liabilities accounting for the majority[16]. - The company's total equity decreased from CNY -110,780,640.01 to CNY -145,889,250.26, indicating a decline in shareholder equity[16]. Shareholder Information - The total number of shareholders at the end of the reporting period was 90,015[9]. - The largest shareholder, Zhejiang Ruikang Investment Co., Ltd., held 11.78% of the shares[9]. - The second-largest shareholder, Henan Agricultural Comprehensive Development Co., Ltd., held 2.30% of the shares[9]. Other Financial Metrics - Basic earnings per share were CNY -0.0285, compared to CNY -0.0385 in the previous year[6]. - The weighted average return on net assets was -159.61%[6]. - The company reported a non-operating income loss of CNY -763,961.03 for the period[9]. - Financial expenses decreased by 21% from CNY 10,758,710.95 to CNY 8,449,959.50 due to reduced loan interest[11]. - Other income decreased significantly by 98% from CNY 3,926,757.50 to CNY 78,100.26, primarily due to a reduction in government subsidies[11]. - Accounts receivable notes increased by 157% from CNY 2,619,583.25 to CNY 6,719,567.74, attributed to sales collection in bank notes[11]. - Inventory decreased by 16% from CNY 104,989,851.35 to CNY 87,902,613.44, indicating an increase in sales and a reduction in stock[11]. - Long-term borrowings increased to CNY 26,000,000.00 during the quarter[11].

Financial Performance - Operating revenue for the first nine months was ¥1,382,924,809.25, reflecting a year-on-year increase of 6.28%[6] - The net profit attributable to shareholders was a loss of ¥109,170,364.68, compared to a loss of ¥44,872,049.72 in the previous year[7] - Basic and diluted earnings per share were both reported at -¥0.1028, compared to -¥0.0423 in the same period last year[7] - The company reported a significant decrease in net profit margin, with a weighted average return on net assets of -131.55%[7] - Net loss for the quarter was ¥52,753,799.64, compared to a loss of ¥49,452,961.95 in the previous year, indicating a decline in profitability[25] - The company's operating revenue for Q3 2017 was approximately ¥439.12 million, an increase of 8.5% compared to ¥404.61 million in Q3 2016[28] - The operating profit for Q3 2017 was a loss of approximately ¥34.28 million, compared to a loss of ¥13.23 million in the same period last year, indicating a significant decline in profitability[28] - The net profit for Q3 2017 was a loss of approximately ¥25.82 million, compared to a loss of ¥15.43 million in Q3 2016, reflecting worsening financial performance[28] - The total comprehensive income for Q3 2017 was approximately -¥52.75 million, compared to -¥49.45 million in the previous quarter, showing a continued decline[28] - Basic and diluted earnings per share for Q3 2017 were both -¥0.046, worsening from -¥0.037 in Q3 2016[28] - The company's total operating costs for Q3 2017 were approximately ¥394.47 million, up from ¥353.80 million in Q3 2016, indicating rising expenses[28] - The investment loss for Q3 2017 was approximately -¥17.45 million, compared to -¥2.86 million in Q3 2016, highlighting increased losses from investments[28] - The company reported a total profit loss of approximately -¥34.43 million for Q3 2017, compared to -¥15.43 million in the same period last year[28] - The total net profit for the first nine months of 2017 was approximately -¥43.79 million, a significant decline from a profit of ¥237,283.64 in the same period last year[28] Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,093,107,028.93, an increase of 0.85% compared to the previous year[6] - Total liabilities increased to ¥2,189,853,444.67 from ¥2,045,681,249.10, indicating a rise in financial obligations[18] - The total assets at the end of the period were ¥1,792,120,641.41, slightly up from ¥1,780,262,292.99 at the beginning of the year[21] - Current assets increased to ¥386,618,145.93 from ¥350,472,222.41 at the start of the year, reflecting a growth of 10.3%[20] - The total liabilities increased to ¥1,299,820,901.42 from ¥1,244,174,031.71, marking a rise of 4.5%[21] - The company's equity decreased to ¥492,299,739.99 from ¥536,088,261.28, reflecting a decline of 8.2%[22] Cash Flow - Net cash flow from operating activities decreased by 35.12% to ¥12,940,412.76 compared to the same period last year[6] - Cash flow per share from operating activities was ¥0.012, down 36.84% from the previous year[6] - Cash inflow from operating activities for the period reached ¥1,661,217,641.32, an increase of 8.93% compared to ¥1,525,012,316.53 in the previous year[32] - Cash inflow from operating activities in Q3 was ¥1,498,119,324.58, compared to ¥1,462,872,599.85 in the previous year, reflecting a growth of 2.4%[36] - Net cash flow from operating activities in Q3 was ¥6,819,778.93, down 89.1% from ¥62,504,927.25 in the same period last year[36] - Cash outflow for purchasing goods and services was ¥1,388,568,066.88, up 11.34% from ¥1,247,183,267.40 year-on-year[32] - Cash inflow from financing activities totaled ¥54,000,000.00, a significant decrease of 76.8% compared to ¥233,135,498.00 in the previous year[33] - Net cash flow from financing activities was ¥13,885,473.40, down 92% from ¥173,497,594.60 in the same period last year[33] - Cash and cash equivalents increased by ¥20,551,536.34, compared to an increase of ¥188,101,377.93 in the previous year[33] - Total cash outflow for investment activities was ¥6,272,401.84, a decrease of 18.4% from ¥7,685,811.81 in the previous year[33] - Net cash flow from investment activities was -¥6,272,401.84, worsening from -¥5,316,073.46 in the same period last year[33] Shareholder Information - The company had a total of 79,333 shareholders at the end of the reporting period[12] - The largest shareholder, Zhejiang Ruikang Investment Co., Ltd., held 11.31% of the shares, amounting to 120,115,072 shares, with a portion pledged[12] Inventory and Receivables - Accounts receivable rose by 284.52% to ¥28,005,520.00 from ¥7,283,301.25, reflecting improved sales collections[13] - Inventory decreased by 32.59% to ¥89,953,831.19 from ¥133,443,860.09, attributed to increased sales and reduced stock levels[13] - Prepayments increased by 62.32% to ¥217,136,531.27 from ¥133,767,788.87, indicating a better sales market[13] - Accounts receivable rose significantly to ¥46,709,263.63 from ¥55,085,160.12, indicating a decrease of 15.5%[20] - Inventory decreased to ¥76,209,945.86 from ¥108,662,736.94, a reduction of 30.0%[20] Taxation - Tax payable increased by 69.53% to ¥12,963,204.51 from ¥7,646,356.21, driven by higher sales leading to increased tax revenue[13] - Operating tax and surcharges surged by 610.93% to ¥9,862,753.53 from ¥1,387,312.20, due to the inclusion of property and land use taxes[13] Investment Income - Investment income decreased by 92.74% to -¥17,962,346.05 from -¥9,319,668.28, reflecting increased losses from associated enterprises[13] - Non-operating income fell by 72.34% to ¥9,257,834.37 from ¥33,468,509.75, primarily due to reduced government subsidy income[13]